Waters Corporation $WAT Stake Raised by IFM Investors Pty Ltd

Posted by on Jul 4th, 2026

IFM Investors Pty Ltd boosted its holdings in shares of Waters Corporation (NYSE:WAT – Free Report) by 67.1% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 18,883 shares of the medical instruments supplier’s stock after acquiring an additional 7,581 shares during the quarter. IFM Investors Pty Ltd’s holdings in Waters were worth $5,623,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Brighton Jones LLC grew its position in Waters by 112.9% during the fourth quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock valued at $471,000 after purchasing an additional 673 shares in the last quarter. Integrated Wealth Concepts LLC lifted its position in Waters by 2.9% in the 1st quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock worth $386,000 after buying an additional 30 shares in the last quarter. Goldman Sachs Group Inc. boosted its stake in shares of Waters by 3.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 200,051 shares of the medical instruments supplier’s stock valued at $73,733,000 after buying an additional 6,976 shares during the period. Empowered Funds LLC grew its holdings in shares of Waters by 16.6% during the 1st quarter. Empowered Funds LLC now owns 1,126 shares of the medical instruments supplier’s stock valued at $415,000 after acquiring an additional 160 shares in the last quarter. Finally, Sivia Capital Partners LLC purchased a new position in shares of Waters during the 2nd quarter valued at $232,000. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Waters Stock Down 0.2%

WAT stock opened at $378.62 on Friday. The company has a current ratio of 1.79, a quick ratio of 1.13 and a debt-to-equity ratio of 0.32. Waters Corporation has a 1 year low of $275.05 and a 1 year high of $414.15. The company has a fifty day simple moving average of $351.53 and a 200 day simple moving average of $347.02. The firm has a market cap of $37.18 billion, a PE ratio of 48.11, a PEG ratio of 2.29 and a beta of 1.20.

Waters (NYSE:WAT – Get Free Report) last posted its earnings results on Tuesday, May 5th. The medical instruments supplier reported $2.70 EPS for the quarter, topping the consensus estimate of $2.31 by $0.39. Waters had a net margin of 11.91% and a return on equity of 15.60%. The firm had revenue of $1.27 billion for the quarter, compared to the consensus estimate of $1.20 billion. During the same period in the prior year, the business posted $2.25 earnings per share. The business’s quarterly revenue was up 91.4% on a year-over-year basis. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. Sell-side analysts anticipate that Waters Corporation will post 14.51 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on WAT. Robert W. Baird set a $387.00 price objective on Waters in a report on Wednesday, May 6th. Bank of America boosted their target price on Waters from $370.00 to $400.00 and gave the company a “neutral” rating in a research note on Tuesday, June 2nd. UBS Group upped their target price on Waters from $330.00 to $375.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 6th. Sanford C. Bernstein started coverage on Waters in a report on Friday, June 26th. They set an “outperform” rating and a $435.00 price target for the company. Finally, Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $350.00 price target on shares of Waters in a research note on Thursday, May 7th. Four analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $396.68.

View Our Latest Report on WAT

About Waters

(Free Report)

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.

Read More

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT – Free Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.